Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring

• Main Authors: Valentina Forni Ogna (Author), Isabelle Bassi (Author), Isabelle Menetrey (Author), Olivier Muller (Author), Eric Tousset (Author), Pierre Fontana (Author), Eric Eeckhout (Author), Chin B. Eap (Author), Bernard Vrijens (Author), Michel Burnier (Author), Grégoire Wuerzner (Author)
• Format: Book
• Published: Frontiers Media S.A., 2017-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aims: Dual platelet inhibition using anti-P2Y12 drugs and aspirin is the standard of care in patients after percutaneous coronary interventions (PCI). Prasugrel and ticagrelor have been shown to be more potent than clopidogrel with less high on-treatment platelet reactivity. Whether differences in l...